Tazarotene
SIGMA/T7080 - ≥98% (HPLC)
Synonym: 6-
CAS Number: 118292-40-3
Empirical Formula (Hill Notation): C21H21NO2S
Molecular Weight: 351.46
Linear Formula: C21H21NO2S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to very faintly yellow |
| form | powder |
| InChI | 1S/C21H21NO2S/c1-4-24-20( |
| InChI key | OGQICQVSFDPSEI-UHFFFAOYSA |
| originator | Allergan |
| Quality Level | 100 ![]() |
| SMILES string | S1CCC(c2c1ccc(c2)C#Cc3ncc |
| solubility | DMSO: >15 mg/mL |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene. |
| Biochem/physiol Actions: | Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene. It is a prodrug of tazarotenic acid, which specifically activates RARb and RARg, only weakly activates RARa, and is inactive at retinoid X receptors (RXRs). In psoriasis, tazarotene normalizes abnormal keratinocyte differentiation and reduces their hyperproliferation. |
| Features and Benefits: | This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound was developed by Allergan . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS08 |
| Signal word | Warning |
| Hazard statements | H361d |
| Precautionary statements | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


